- RecruitingPHASE3
Study to Assess the Efficacy and Safety of IMVT-1402 in Participants With Mild to Severe Generalized Myasthenia Gravis
This study is testing a new medicine, IMVT-1402, for adults with a condition called myasthenia gravis. The aim is to see if it's safe and helps improve daily life for those with mild to severe symptoms.
For: Generalized Myasthenia GravisUnited States · Argentina · Czechia - Active not recruitingPHASE2
A Study to Evaluate the Efficacy, Safety, and Tolerability of IMVT-1402 in Adult Participants With Active, Difficult to Treat Rheumatoid Arthritis
This study is testing a new medicine, IMVT-1402, for adults with a type of rheumatoid arthritis that's been hard to treat. It checks if the medicine works and is safe compared to a dummy treatment.
For: Rheumatoid ArthritisUnited States · Argentina · Bulgaria - RecruitingPHASE2
A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' Disease
This study is looking for adults with Graves' disease whose thyroid is overactive despite medication. It aims to see if a new medicine, IMVT-1402, is safe and helps control their thyroid better than a dummy medicine. We want to find a better treatment.
For: Graves' DiseaseUnited States · Australia · Brazil - RecruitingPHASE2
A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' Disease
This study is testing a new medicine, IMVT-1402, for adults with Graves' disease whose thyroid is still overactive despite current treatment. We want to see if it works, is safe, and is well-tolerated. It's a Phase 2 trial. You can find out more if you're interested.
For: Graves' DiseaseUnited States · Belgium · Georgia - Active not recruitingPHASE2
A Study to Assess the Safety, Tolerability, and Efficacy of IMVT-1402 in Participants With Cutaneous Lupus Erythematosus (CLE)
This study is testing a new medicine, called IMVT-1402, for people with specific types of lupus that affect the skin. Researchers want to see if it's safe, if people can tolerate it, and if it helps improve skin symptoms compared to a dummy medicine.
For: Subacute Cutaneous Lupus Erythematosus · Chronic Cutaneous Lupus ErythematosusUnited States · Argentina · Bulgaria - Active not recruitingPHASE2
Efficacy and Safety of IMVT-1402 in Adult Participants With Primary Sjogren's Disease With Moderate to Severe Systemic Disease Activity
This study is testing a new drug, IMVT-1402, for adults with a moderate to severe form of Sjögren's Syndrome. It aims to see if the drug is safe and helps reduce symptoms compared to a dummy drug (placebo) over 24 weeks.
For: Primary Sjögren's SyndromeUnited States · Argentina · Canada - Enrolling by invitationPHASE2
A Long-Term Extension Study of IMVT-1402 in Adult Participants With Graves' Disease (GD)
This study is for adults with Graves' Disease who have already taken part in another trial for a medicine called IMVT-1402. It's a long-term study to see how well this medicine works and if it's safe over a longer period, helping us understand more about this treatment.
For: Graves' DiseaseUnited States · Australia · Bulgaria